Journal article
HSV-2 vaccine: Current state and insights into development of a vaccine that targets genital mucosal protection
Abstract
HSV-2 is one of the most prevalent sexually transmitted infections that result in significant morbidity and financial burden on health systems around the world. Recurrent and asymptomatic re-activation accompanied by viral shedding is common among sero-positive individuals, leading to relatively high efficiency of transmission. Prophylactic HSV-2 vaccines are the best and cheapest option to address the problems associated with HSV-2 infections …
Authors
Roth K; Ferreira VH; Kaushic C
Journal
Microbial Pathogenesis, Vol. 58, , pp. 45–54
Publisher
Elsevier
Publication Date
May 2013
DOI
10.1016/j.micpath.2012.11.001
ISSN
0882-4010